伴发血小板减少症的下肢动脉栓塞围手术期治疗

李文毅; 蔡传奇; 郑鸿; 符晓阳; 金毕; 滕云飞

doi:10.13201/j.issn.1009-5918.2012.02.020

伴发血小板减少症的下肢动脉栓塞围手术期治疗

- 华中科技大学同济医学院附属协和医院血管外科(武汉, 430022)

详细信息

通讯作者: 郑鸿,E-mail:zhenghong559@gmail.com

中图分类号: R558

收稿日期: 2012-01-12

Perioperative therapeutical strategies of arterial embolism of lower limbs associated with thrombocytopenia

- Department of Vascular Surgery, Union Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan 430022, China

More Information

Corresponding author: ZHENG Hong, E-mail: zhenghong559@gmail.com

Received Date: 12 January 2012

摘要

摘要: 目的：探讨伴发血小板减少症的下肢动脉栓塞围手术期的治疗。方法：回顾性分析2008-12-2011-10期间手术取栓的5例伴发血小板减少症的下肢动脉栓塞患者的临床资料。结果：5例患者均手术成功，无创面渗血。1例取栓后急性肾功能不全；2例患者再次动脉栓塞后肢体坏死截肢。随访18个月（4个月~27个月），1例19个月后死于晚期胃癌，其余病例生活状态良好。结论：血小板减少不是急诊动脉取栓手术的绝对禁忌症；根据具体的情况调整治疗方案，创造条件尽早手术是十分重要的。
- 血小板减少症 /
- 动脉栓塞 /
- 围手术期
Abstract: Objective: To explore the perioperative therapeutical strategiestreatments of arterial embolism associated with thrombocytopenia perioperatively.Method: Retrospective analysis of clinical data in 5 patients with arterial embolism associated with thrombocytopenia were preformed from Aug.2008 through Oct.2011.Result: Surgical eEmbolectomy was successfully performed in all 5 patients without blood oozing.Acute renal insufficiency was seen in 1 case after embolectomy.Lower limbs were amputated in 2 cases due to repeated arterial embolism.At a median follow up of 18 months(range,4-27),1 patient died of advanced gastric cancer after 19 months and others were cured of their symptoms.Conclusion: Thrombocytopenia with arterial embolism is not absolute contraindication for urgent arterial embolectomy.The effective and comprehensive treatments in perioperative period are very important for succeeding operation.
- thrombocytopenia /
- arterial embolism /
- perioperation

HTML全文

参考文献(13)

[1]	KHORANA A A.Cancer and thrombosis:implications of published guidelines for clinical practice[J].Ann Oncol,2009,20:1619-1630.
[2]	BLANN A D,DUNMORE S.Arterial and venous thrombosis in cancer patients[J].Cardiol Res Pract,2011,2011:394740-.
[3]	SLICHTER S J.Relationship between platelet count and bleeding risk in thrombocytopenic patients[J].Transfus Med Rev,2004,18:153-167.
[4]	HEDDLE N M,COOK R J,SIGOUIN C,et al.A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia[J].Transfusion,2006,46:903-911.
[5]	SLICHTER S J,KAUFMAN R M,ASSMANN S F,et al.Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage[J].N Engl J Med,2010,362:600-613.
[6]	TOSETTO A,BALDUINI C L,CATTANEO M,et al.Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemo-stasis and Thrombosis(SISET)[J].Thromb Res,2009,124:e13-e18.
[7]	杨广顺,钱毅,卢军华,等.肝癌切除附加脾切除、门奇断流治疗肝癌合并门脉高压症(附67例报告)[J].中华肝胆外科杂志,2004,10(10):656-659.
[8]	WARKENTIN T E.Heparin-Induced Thrombocytopenia and Vascular[J].Surgery Acta chir belg,2004,104:257-265.
[9]	OHTEKI H,FURUKAWA K,OHNISHI H,et al.Clinical experience of Argatroban for anticoagulation in cardiovascular surgery[J].Jpn J Thorac Cardiovasc Surg,2000,48:39-46.
[10]	TOKUDA Y,MATSUMOTO M,SUGITA T,et al.Vascular Surgery Using Argatroban in a Patient With a History of Heparin-Induced Thrombocytopenia[J].Circ J,2003,67:889-890.
[11]	NANDA M M,KAUFLIN M J,JAIN P G,et al.Use of Argatroban as a Procedural and Bridging Anticoagulant in a Patient Undergoing Carotid Endarterectomy with Concomitant Atrial Fibrillation[J].Ann Pharmacother,2011,45:e16-e16.
[12]	FRANCHINI M.Heparin-induced thrombocytopenia:an update[J].Thromb J,2005,3:14-14.
[13]	GASPAROVIC H,NATHAN N S,FITZGERALD D,et al.Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopedia[J].Ann Thorac Surg,2004,78:e89-e91.